Extracellular Signal-regulated Kinase Induces the Megakaryocyte GPIIb/CD41 Gene Through MafB/Kreisler
Overview
Affiliations
Extracellular signal-regulated kinase (ERK) facilitates cell cycle progression in most mammalian cells, but in certain cell types prolonged signaling through this pathway promotes differentiation and lineage-specific gene expression through mechanisms that are poorly understood. Here, we characterize the transcriptional regulation of platelet GPIIb integrin (CD41) by ERK during megakaryocyte differentiation. ERK-dependent transactivation involves the proximal promoter of GPIIb within 114 bp upstream of the transcriptional start site. GATA, Ets, and Sp1 consensus sequences within this region are each necessary and function combinatorially in ERK-activated transcription. MafB/Kreisler is induced in response to ERK and synergizes with GATA and Ets to enhance transcription from the proximal promoter. The requirement for MafB in promoter regulation is demonstrated by inhibition of transactivation following dominant-negative or antisense suppression of MafB function. Thus, ERK promotes megakaryocyte differentiation by coordinate regulation of nuclear factors that synergize in GPIIb promoter regulation. These results establish a novel role for MafB as a regulator of ERK-induced gene expression.
Trametinib, an anti-tumor drug, promotes oligodendrocytes generation and myelin formation.
Yang Y, Suo N, Cui S, Wu X, Ren X, Liu Y Acta Pharmacol Sin. 2024; 45(12):2527-2539.
PMID: 38871922 PMC: 11579360. DOI: 10.1038/s41401-024-01313-9.
MicroRNA target homeobox messenger RNA in HIV induced hematopoietic inhibition.
Koka P, Ramdass B Front Cell Dev Biol. 2024; 12:1382789.
PMID: 38721526 PMC: 11076784. DOI: 10.3389/fcell.2024.1382789.
Zarrabi M, Afzal E, Asghari M, Mohammad M, Aboulkheyr Es H, Ebrahimi M J Cell Mol Med. 2017; 22(3):1464-1474.
PMID: 28994199 PMC: 5824365. DOI: 10.1111/jcmm.13379.
Kim J, Choi G, Ko K, Kim J, Oh S, Park Y PLoS One. 2016; 11(9):e0162519.
PMID: 27603512 PMC: 5014326. DOI: 10.1371/journal.pone.0162519.
Han L, Schubert C, Kohler J, Schemionek M, Isfort S, Brummendorf T J Hematol Oncol. 2016; 9(1):45.
PMID: 27177927 PMC: 4894373. DOI: 10.1186/s13045-016-0275-0.